Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4800032
Max Phase: Preclinical
Molecular Formula: C23H27N5O2S
Molecular Weight: 437.57
Molecule Type: Unknown
Associated Items:
ID: ALA4800032
Max Phase: Preclinical
Molecular Formula: C23H27N5O2S
Molecular Weight: 437.57
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cc(-c2cnc3c(N4CCCC(CNC(=O)C5CC5)C4)snc3c2)ccc1N
Standard InChI: InChI=1S/C23H27N5O2S/c1-30-20-10-16(6-7-18(20)24)17-9-19-21(25-12-17)23(31-27-19)28-8-2-3-14(13-28)11-26-22(29)15-4-5-15/h6-7,9-10,12,14-15H,2-5,8,11,13,24H2,1H3,(H,26,29)
Standard InChI Key: RKPJQLHQSKPTDA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 437.57 | Molecular Weight (Monoisotopic): 437.1885 | AlogP: 3.69 | #Rotatable Bonds: 6 |
Polar Surface Area: 93.37 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.74 | CX LogP: 2.73 | CX LogD: 2.73 |
Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.57 | Np Likeness Score: -1.28 |
1. Martinez-Gualda B,Saul S,Froeyen M,Schols D,Herdewijn P,Einav S,De Jonghe S. (2021) Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase., 213 [PMID:33497888] [10.1016/j.ejmech.2021.113158] |
Source(1):